company background image
STRR

Star Equity Holdings NasdaqGM:STRR Stock Report

Last Price

US$0.93

Market Cap

US$14.0m

7D

-1.1%

1Y

-70.0%

Updated

29 Jun, 2022

Data

Company Financials +
STRR fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

STRR Stock Overview

Star Equity Holdings, Inc. provides healthcare solutions in the United States and internationally.

Star Equity Holdings Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Star Equity Holdings
Historical stock prices
Current Share PriceUS$0.93
52 Week HighUS$4.67
52 Week LowUS$0.72
Beta0.42
1 Month Change-6.00%
3 Month Change-17.69%
1 Year Change-70.00%
3 Year Change-84.80%
5 Year Change-97.79%
Change since IPO-99.21%

Recent News & Updates

Shareholder Returns

STRRUS HealthcareUS Market
7D-1.1%4.1%1.6%
1Y-70.0%5.0%-20.8%

Return vs Industry: STRR underperformed the US Healthcare industry which returned 3.8% over the past year.

Return vs Market: STRR underperformed the US Market which returned -20.4% over the past year.

Price Volatility

Is STRR's price volatile compared to industry and market?
STRR volatility
STRR Average Weekly Movement12.1%
Healthcare Industry Average Movement9.5%
Market Average Movement8.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.2%

Stable Share Price: STRR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: STRR's weekly volatility (12%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1985458Rick Colemanhttps://www.starequity.com

Star Equity Holdings, Inc. provides healthcare solutions in the United States and internationally. It operates through four segments: Diagnostic Services, Diagnostic Imaging, Construction, and Investments. It offers imaging services primarily to cardiologists, internal medicine physicians, and family practice doctors; and imaging systems, including nuclear cardiac and general purpose nuclear imaging systems to physician offices and hospitals.

Star Equity Holdings Fundamentals Summary

How do Star Equity Holdings's earnings and revenue compare to its market cap?
STRR fundamental statistics
Market CapUS$14.03m
Earnings (TTM)-US$13.95m
Revenue (TTM)US$109.25m

0.1x

P/S Ratio

-1.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
STRR income statement (TTM)
RevenueUS$109.25m
Cost of RevenueUS$92.43m
Gross ProfitUS$16.83m
Other ExpensesUS$30.78m
Earnings-US$13.95m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.92
Gross Margin15.40%
Net Profit Margin-12.77%
Debt/Equity Ratio30.0%

How did STRR perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is STRR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for STRR?

Other financial metrics that can be useful for relative valuation.

STRR key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.3x
Enterprise Value/EBITDA-8.4x
PEG Ration/a

Price to Sales Ratio vs Peers

How does STRR's PS Ratio compare to its peers?

STRR PS Ratio vs Peers
The above table shows the PS ratio for STRR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average1.4x
GMVD G Medical Innovations Holdings
2.9xn/aUS$14.9m
AMS American Shared Hospital Services
0.8xn/aUS$13.7m
CLRD Clearday
1.5xn/aUS$18.1m
IDXG Interpace Biosciences
0.3x15.2%US$13.2m
STRR Star Equity Holdings
0.1x7.7%US$14.0m

Price-To-Sales vs Peers: STRR is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (1.4x).


Price to Earnings Ratio vs Industry

How does STRR's PE Ratio compare vs other companies in the US Healthcare Industry?

Price-To-Sales vs Industry: STRR is good value based on its Price-To-Sales Ratio (0.1x) compared to the US Healthcare industry average (1.4x)


Price to Sales Ratio vs Fair Ratio

What is STRR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

STRR PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.1x
Fair PS Ratio0.4x

Price-To-Sales vs Fair Ratio: STRR is good value based on its Price-To-Sales Ratio (0.1x) compared to the estimated Fair Price-To-Sales Ratio (0.4x).


Share Price vs Fair Value

What is the Fair Price of STRR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate STRR's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate STRR's fair value for valuation analysis.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate STRR's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is Star Equity Holdings forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


79.5%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: STRR is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: STRR is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: STRR is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: STRR's revenue (7.7% per year) is forecast to grow slower than the US market (8.3% per year).

High Growth Revenue: STRR's revenue (7.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if STRR's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Past Performance

How has Star Equity Holdings performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


19.0%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: STRR is currently unprofitable.

Growing Profit Margin: STRR is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: STRR is unprofitable, but has reduced losses over the past 5 years at a rate of 19% per year.

Accelerating Growth: Unable to compare STRR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: STRR is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (9.8%).


Return on Equity

High ROE: STRR has a negative Return on Equity (-27.1%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is Star Equity Holdings's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: STRR's short term assets ($44.8M) exceed its short term liabilities ($30.7M).

Long Term Liabilities: STRR's short term assets ($44.8M) exceed its long term liabilities ($6.0M).


Debt to Equity History and Analysis

Debt Level: STRR has more cash than its total debt.

Reducing Debt: STRR's debt to equity ratio has reduced from 31.4% to 30% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: STRR has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: STRR has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 60.2% each year


Discover healthy companies

Dividend

What is Star Equity Holdings's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate STRR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate STRR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if STRR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if STRR's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: STRR is not paying a notable dividend for the US market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as STRR has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

3.4yrs

Average management tenure


CEO

Rick Coleman (65 yo)

0.25

Tenure

Mr. Richard Kenneth Coleman, Jr., also known as Rick, has been Chief Executive Officer of Star Equity Holdings, Inc. from March 2022 and serves as Director since May 31, 2022. He was Chief Operating Office...


Leadership Team

Experienced Management: STRR's management team is considered experienced (3.4 years average tenure).


Board Members

Experienced Board: STRR's board of directors are considered experienced (8.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: STRR insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 200.5%.


Top Shareholders

Company Information

Star Equity Holdings, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Star Equity Holdings, Inc.
  • Ticker: STRR
  • Exchange: NasdaqGM
  • Founded: 1985
  • Industry: Health Care Services
  • Sector: Healthcare
  • Implied Market Cap: US$14.028m
  • Shares outstanding: 15.08m
  • Website: https://www.starequity.com

Number of Employees


Location

  • Star Equity Holdings, Inc.
  • 53 Forest Avenue
  • Suite 101
  • Old Greenwich
  • Connecticut
  • 6870
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/29 00:00
End of Day Share Price2022/06/29 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.